| Literature DB >> 26933487 |
Zhanmin Lin1, H Martijn de Gruiter2, Jantine A C Broek3, Heleen van 't Spijker3, Elize D Haasdijk1, David Cox3, Sureyya Ozcan3, Gert W A van Cappellen2, Adriaan B Houtsmuller2, Rob Willemsen4, Chris I de Zeeuw1,5, Sabine Bahn3,1.
Abstract
BACKGROUND: Fragile X syndrome (FXS) is a single-gene disorder that is the most common heritable cause of intellectual disability and the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by an expansion of trinucleotide repeats in the promoter region of the fragile X mental retardation gene (Fmr1). This leads to a lack of fragile X mental retardation protein (FMRP), which regulates translation of a wide range of messenger RNAs (mRNAs). The extent of expression level alterations of synaptic proteins affected by FMRP loss and their consequences on synaptic dynamics in FXS has not been fully investigated.Entities:
Keywords: Electron microscopy; Fragile X syndrome (FXS); Mass spectrometry (MS); Quantitative live-cell imaging; Synaptic transmission
Mesh:
Substances:
Year: 2016 PMID: 26933487 PMCID: PMC4772588 DOI: 10.1186/s13229-016-0080-1
Source DB: PubMed Journal: Mol Autism Impact factor: 7.509
Fig. 1Overview of experimental design. In the mass spectrometry studies, the Fmr1 KO mouse model was compared with WT mice. Frontal cortex, hippocampal and cerebellar brain tissues were used for protein profiling using LC-MSE. For synaptosomes, both hippocampal and cerebellar tissues were used for LC-MSE and SRM-MS studies. Data analysis resulted in the identification of significant protein changes. For live-cell imaging, neurons of the Fmr1 KO mouse model were cultured and compared with WT mice for both hippocampus and cerebellum. These neurons were stained with FM1-43 dye that specifically stains synaptic vesicles. For electron microscopy, Fmr1 was specifically knocked down in Purkinje cells and these cells were used for ultrastructural analysis. Data analysis was performed in instrument specific programmes, and statistical analysis was performed using R statistical programming language
Protein changes validated using SRM-MS in the mouse brain synaptosome fractions
| HC | CB | |||||
|---|---|---|---|---|---|---|
| Protein name | Ratio Fmr1 KO/WT |
|
| Ratio Fmr1 KO/WT |
|
|
| Signal transduction | ||||||
| Plasma membrane calcium-transporting ATPase 2 (AT2B2)a, b, e | 1.11 | 0.6403 | 0.8270 | 1.16 | 0.2314 | 0.2953 |
| Sodium potassium transporting ATPase alpha 1 (AT1A1)a | 0.99 | 0.8710 | 0.9194 | 1.32 |
|
|
| Sodium potassium transporting ATPase alpha 3 (AT1A3)a | 0.74 |
|
| 1.66 |
|
|
| Sodium potassium transporting ATPase beta 1 (AT1B1)a | 1.01 | 0.9524 | 0.9524 | 1.27 |
|
|
| Sodium potassium transporting ATPase beta 2 (AT1B2)a | 1.21 |
| 0.1874 | 1.19 |
|
|
| Synaptic vesicle glycoprotein 2A (SV2A)b, d | 1.02 | 0.6529 | 0.8270 | 1.20 |
|
|
| Synaptic vesicle glycoprotein 2B (SV2B)b | 0.86 | 0.1754 | 0.3715 | 0.92 | 0.5270 | 0.5909 |
| Neuronal development | ||||||
| Brain acid soluble protein 1 (BASP1)c | 0.77 |
|
| 1.75 |
|
|
| Neuromodulin (NEUM)a | 0.88 |
| 0.1874 | 0.77 |
|
|
| Neurotransmission: GABA/glutamate-related proteins | ||||||
| BTB POZ domain containing protein KCTD12 (KCD12)a | 0.73 |
| 0.0004 | 1.17 |
|
|
| Glutamate receptor 1 (GRIA1)b, d | 0.83 |
| 0.1874 | 1.77 |
|
|
| Glutamate receptor 3 (GRIA3)b, d | 0.87 | 0.1760 | 0.3715 | 1.34 |
|
|
| Succinate semialdehyde dehydrogenase (SSDH)a | 1.06 | 0.3880 | 0.5897 | 0.93 | 0.3833 | 0.4432 |
| Vesicular glutamate transporter 1 (VGLU1)a | 1.02 | 0.8017 | 0.8934 | 1.23 |
|
|
| Excitatory amino acid transporter 1 (EAA1)a | 1.14 | 0.3178 | 0.5251 | 1.13 | 0.3431 | 0.4095 |
| Glutamate decarboxylase 1 (DCE1)b | 0.94 | 0.6107 | 0.8270 | 0.95 | 0.7279 | 0.7782 |
| Glutamate decarboxylase 2 (DCE2)b, d | 0.81 | 0.3422 | 0.5419 | 1.27 | 0.2416 | 0.2979 |
| FMRP-related proteins | ||||||
| Cytoplasmic FMR1-interacting protein 1 (CYFP1)b, d | 0.65 |
| 0.0973 | 1.45 |
|
|
| Cytoplasmic FMR1-interacting protein 2 (CYFP2)b | 1.04 | 0.7761 | 0.8934 | 1.41 |
|
|
| Fragile X mental retardation syndrome-related 2 (FXR2)c | 1.04 | 0.7108 | 0.8713 | 1.26 |
|
|
* this is the multiply sign
The table includes Uniprot ID, ratios (calculated based on average), P values and adjusted P values (Q). Significant proteins are indicated in italics
aProteins indicated in LC-MSE brain study
bProteins indicated in LC-MSE synaptosome study
cProteins associated with FMRP in literature
dIsoforms of indicated proteins in B or S
eFamily member of proteins indicated in B or S
Fig. 2Differences in synaptic bouton unloading of FM1-43 dye in hippocampal (HC) and cerebellar (CB) neurons. (top left) Weak unloading boutons are less synaptically active, which translates into the release of fewer synaptic vesicles and neurotransmitters. Strong unloading boutons have a greater number of synaptic vesicle exocytosis and are therefore expected to release neurotransmitters more actively. Kinetics of FM1-43 unloading of weak unloading boutons in the hippocampus showed a significant difference with a p value of 0.004 during stimulation with 50 mM KCl and (top right) a significant difference with a p value of 0.008 for strong unloading boutons in the hippocampus. In the cerebellum, the weak unloading boutons showed a highly significant change with a p value of 2.17 × 10−9 (below left), as well as a highly significant change with a p value of 2 × 10−16 for strong unloading of FM1-43 dye from synaptic boutons (below right). The p values were obtained by regression analysis with ANOVA comparing Fmr1 KO with WT mouse primary neurons
Fig. 3Ultrastructural analysis of Purkinje cell synapses. Fmr1 KO (a) as compared to WT (b) Purkinje cell synapses revealed a negative correlation of density vs. active zone (AZ) length in Fmr1 KO (c), while this was positive for WT (d). e–g No significant differences were observed for AZ length, presynaptic area and vesicle density. In a and b: white rectangle= AZ; white circle= synaptic vesicles; and dark stained area= presynaptic area
Fig. 4Changes observed in hippocampal and cerebellar synapses using mass spectrometry and microscopy studies. In the hippocampus (above), significant changes were observed for ATPases and a significant decrease of GABA receptor proteins. Furthermore, the microscopy studies indicated decreased synaptic vesicle release in hippocampal neurons. This might indicate decreased excitatory synaptic transmission in the hippocampus. A significant increase of ATPases, GABA and glutamate receptors and synaptic vesicle proteins were observed in cerebellar synapses (below). This increase in synaptic activity was also supported by the microscopy studies, in which cerebellar neurons show an increase of synaptic vesicle dynamics, suggesting an increased inhibitory output from the cerebellum